563 F.Supp.3d 259
S.D.N.Y.2021Background
- Omega Healthcare issued a $15 million loan to its second-largest tenant, Orianna, in May 2017; plaintiffs allege defendants omitted disclosure that Orianna could not pay rent without the Loan.
- District court in Omega I found those omissions materially misleading but dismissed for failure to plead scienter; the Second Circuit in Omega II reversed as to scienter (conscious recklessness) and held the omission actionable.
- Plaintiffs filed a second amended complaint (SAC) adding February 2017 disclosures to expand the class period back to Feb 2017; defendants moved to dismiss on loss-causation and failure-to-state grounds for Feb statements.
- Plaintiffs alleged market losses tied to July and October 2017 disclosures: ~4% drop in July (cash-basis discussion) and ~6.8% drop in October (cash accounting, $9.5M provision, revised guidance).
- The district court (this opinion) held plaintiffs adequately pled loss causation for the May–Oct 2017 omissions (the undisclosed Loan) but dismissed with prejudice the February 2017 claims; the class period begins May 3, 2017.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether plaintiffs plead loss causation for omissions about the Loan (May–Oct 2017) | Market drops in July and October were caused by disclosure/realization of risks concealed by omission of the Loan (foreseeable materialization of concealed risk). | Interim disclosures and other public statements already warned the market about Orianna, so plaintiffs cannot show the concealed risk proximately caused losses. | Loss causation adequately pleaded: the July/Oct disclosures revealed materialized risks within the zone concealed by the omission and caused market declines. |
| Whether February 8 press‑release statements required disclosure of Orianna’s missed rent/foreseeable inability to pay | Broad positive statements about results and balance-sheet strength rendered those statements misleading because they omitted Orianna’s operational failures and missed rent. | Statements were literally true and generic; no close nexus putting Orianna specifically "in play" to require disclosure. | Dismissed: no sufficiently close nexus; press release did not make Orianna-specific omissions misleading. |
| Whether February 9 earnings‑call answers created a duty to disclose Orianna’s missed January/February rent | CEO/CFO answered questions about operator stress and portfolio actions but omitted Orianna’s missed rent, rendering answers misleading. | Answers were accurate and generic or directed to other operators; no duty to disclose operator‑specific, non‑material events. | Dismissed: statements were either accurate or too generalized to require Orianna‑specific disclosure. |
| Whether the Feb 24, 2017 Form 10‑K (Item 303, MD&A, and ASC 855) required disclosure of Orianna’s two missed rent payments or other Orianna issues | Item 303, MD&A, and GAAP subsequent‑event rules required disclosure of known trends/uncertainties and nonrecognized subsequent events (two missed payments and ongoing distress). | Two missed payments do not create a legally cognizable "trend" under Item 303; accurate historical financials are not misleading; ASC 855 does not compel disclosure of immaterial/non‑quantitative subsequent events. | Dismissed with prejudice as to Feb 2017 10‑K claims: two months’ misses not a trend under Item 303; no duty under ASC 855; historical statements not misleading. |
Key Cases Cited
- Dura Pharm., Inc. v. Broudo, 544 U.S. 336 (2005) (loss causation requires causal connection between misrepresentation and loss)
- Lentell v. Merrill Lynch & Co., 396 F.3d 161 (2d Cir. 2005) (tests for loss causation: corrective disclosure and materialization of concealed risk)
- Loreley Fin. (Jersey) No. 3 Ltd. v. Wells Fargo Sec., LLC, 797 F.3d 160 (2d Cir. 2015) (pleading loss causation requires plausible link; pleading burden is not heavy)
- Carpenters Pension Tr. Fund of St. Louis v. Barclays PLC, 750 F.3d 227 (2d Cir. 2014) (alternative loss‑causation theories recognized)
- Setzer v. Omega Healthcare Invs., Inc., 968 F.3d 204 (2d Cir. 2020) (Second Circuit: omission of Loan was actionable and scienter adequately alleged under conscious‑recklessness)
- In re Omega Healthcare Invs., Inc. Sec. Litig., 375 F. Supp. 3d 496 (S.D.N.Y. 2019) (district court opinion addressing materiality and scienter; earlier dismissal on scienter ground)
- Lattanzio v. Deloitte & Touche LLP, 476 F.3d 147 (2d Cir. 2007) (disclosures that make going‑concern risk unambiguously apparent can defeat loss‑causation claims)
- In re The Warnaco Group, Inc. Sec. Litig., 388 F. Supp. 2d 307 (S.D.N.Y. 2005) (explicit going‑concern warnings can make insolvency risk apparent to the market)